The frequence of invasive fungous infections has risen dramatically in recent old ages. Opportunist invasive fungal infections ( IFIs ) are a major cause of morbidity and mortality in immunocompromised patients. The bulk of IFI occur in patients with haematological malignances ( HM ) , peculiarly in patients with acute myeloid leukaemia ( AML ) and those who have undergone allogeneic haematopoietic root cell organ transplant ( allo-HSCT ) . The dramatically addition of IFD during the last decennaries is attributed to host defence damage due to intensive cytotoxic chemotherapies, haematopoietic root cell organ transplant, ablative radiation therapy, usage of corticoids, cyclosporine and new immunosuppressive agents. Aspergillus spp. infections remain the most common cause of decease in HM ; the overall incidence of Aspergillus spp. ranges from 0.3 % to 12 % depending on the implicit in haematological status. Patients undergoing allo-HSCT appear to hold two periods for the peak happening of invasive brooder pneumonia ( IA ) . The first period is before engraftment, during the neutropenic province. The 2nd period occurs subsequently during the postengraftment period, when patients are on immunosuppressive therapy or suffer for GVHD. Aspergillus species are omnipresent molds to which worlds are normally exposed. Of about 180 species, it is estimated that 34 are medically important. Most individuals who are exposed to the fungus remain symptomless. Patients who are immunocompromised, nevertheless, are susceptible to more terrible invasive disease, normally marked by an acute progressive infection, frequently ensuing in decease. The forecast of IA is inexorable, with a instance mortality rate of 58 % . Although newer, less toxic fungicidal agents have been developed, successful direction of IA is contingent on early sensing, which, unluckily, can be hard. The gilded criterion for the diagnosing of IA is tissue biopsy showing invasion on histopathological scrutiny and designation of the being in civilization. However, obtaining tissue specimens for the diagnosing of IA is frequently hard because patients in whom IA is suspected frequently have medical conditions, such as thrombopenia that preclude biopsy. A recent diagnostic mode for IA is the galactomannan ( GM ) check. GM is portion of the outer bed of the Aspergillus cell wall, and is released during growing of the fungus at the tips of hyphae. GM is a cell wall constituent of many Fungis, including Aspergillus, Penicillium, Paecilomyces, and Geotrichum species. The antigen can be detected utilizing a commercially available sandwich ELISA ( Platelia Aspergillus, BioRad, France ) ( PA-ELISA ) , which employs a monoclonal antibody ( EB-A2 ) that binds galactofuran antigenic determinant of the GM antigen. In 2011, all patients with HSCT at the Fundeni Clinical Institute, Bucharest, were screened with serum GM ELISAs while hospitalized. We performed all checks on peripheral blood serum, as per criterion protocols. A positive GM trial consequence was defined as two back-to-back trials with an optical denseness index of & A ; acirc ; & A ; deg ; ? 0.5 or a individual trial with an optical denseness index of & A ; acirc ; & A ; deg ; ?0.8. The day of the month of the first positive GM trial consequence was considered the day of the month of diagnosing of IA, in bad patients with radiological marks of IA. Patients were retrospectively evaluated from January 1 to December 31, 2011. Datas from all clinical informations for naming fungous infections, including microbiology civilizations, cytology studies from bronchoalveolar lavage processs, biopsy findings, and CT scans, were reviewed. We calculated the sensitiveness, specificity, negative and positive prognostic values of the GM ELISA, in respects to probable or turn out IA infection. GM ELISA was tested 230 times among the 162 patients with haematopoietic root cell grafts. After a complete retrospective reappraisal of each patient & A ; acirc ; ˆ™s clinical class, 102 of the 162 patients had no clinical, radiographic, or microbiological standards for IA. Of the staying 60 patients, one had proven IA by biopsy ( one patient with pneumonic brooder pneumonia by unfastened lung biopsy ) . Six patients had a likely diagnosing of IA, and 53 had a possible diagnosing if IA. Thirteen of the 162 ( 8.02 % ) patients had at least one positive GM ELISA trial. GM checks were positive in six of the seven proven or likely IA patients. We identified seven false positive GM checks, in patients with at least one positive GM check and no proven or likely IA. Four of these false positive consequences were considered to be due to the usage of antibiotics. One individual patient was diagnosed with AI and had a negative GM consequences, likely due to the old exposure of antimould prophylaxis. Ninety-six of the receivers were male ( 59.9 % ) . With one exclusion, all the tried patients received peripheral haematopoietic root cells. Three grownup patients had a positive phlegm direct microscopic test for Aspergillus. Minimally invasive trials for the diagnosing of brooder pneumonia pose several troubles, as the coagulopathy caused by pancytopenia, in association with HSCT, can take to broad biopsies with low sensitiveness thresholds. In our experience, serum GM ELISA as a showing trial besides provides sufficient sensitiveness and specificity in observing IA after HSCT. The trial has besides a really good negative prognostic value -0.993. Our informations may be limited by the fact that merely one of 162 patients had a proven diagnosing of IA, but due to the clinical state of affairs of the patients, more invasive diagnosing processs were inappropriate. Within the past decennary sensing of the Aspergillus antigen galactomannan has become an of import and dependable tool for the early diagnosing of invasive brooder pneumonia. The trial has a high sensitiveness and specificity, but it non replaces careful microbiological and clinical rating. There is now standardized a word-wide cut-off 0.5 and both false negative and false positive responsiveness is encountered. There are many false-positive trial consequences reported with the GM check. Because produces GM, it is non surprising that a figure of & A ; Icirc ; ?-lactam antibiotics, including Penicillium, piperacillin/tazobactam, amoxicillin/clavulanate, Principen have yielded positive Platelia EIA consequences. False positive consequences may happen more often in kids and it was suggested that GM nowadays in milk or protein-rich foods is the cause of false-positive consequences in kids. The falsepositive rate was reported to be high in up to 83 % of newborn babes. Other factors related with false positive consequences are: infection with beings that portion cross-reacting antigens with Aspergillus, reduced nephritic clearance, patients undergoing liver organ transplant for autoimmune liver disease, patients undergoing cyclophosphamide intervention and patients undergoing lung organ transplant for cystic fibrosis and chronic clogging pneumonic disease. The chief grounds for a false-negative consequence are exposure to antifungal agents and high cut-off values, but there are besides others grounds for false negative trials: inappropriate diagnostic standards for IA, unequal frequence of galactomannan testing, patients with nonor minimally invasive manifestation of brooder pneumonia, low volume of trying or long-run storage of samples. Antigen has been detected in organic structure fluids other than serum: broncho-alveolar lavage fluid ( BAL ) or cardinal nervous system ( CNS ) . Although these specimens are non standardized yet, they may be superior to serum for proving in certain fortunes. It is recognized now that GM sensing facilitates early diagnosing of IA and can predate CT findings by one hebdomad or more. Twice-weekly antigenemia monitoring is really utile for observing IA in high hazard patients, inclusive allogeneic root cell receivers, but proving GM antigenemia can be usage besides for supervising the effectivity of the therapy. Our findings indicate that testing with Platelia Aspergillus galactomannan antigenemia assay may help doctors in doing an early diagnosing of IA, in correlativity with clinical and radiological standards and stand for a extremely specific diagnostic tool for observing invasive brooder pneumonia in patients undergoing HSCT.